Catalyst Wire Dossier Catalyst Wire Dossier

PRO-148 ophthalmic solution

PRO-148 ophthalmic solution · Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-148 ophthalmic solution, covering 2018-10-30 to 2018-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome [Phase 2]

See pricing